128 related articles for article (PubMed ID: 7081970)
1. Interaction of metronidazole with resistant and susceptible Bacteroides fragilis.
McLafferty MA; Koch RL; Goldman P
Antimicrob Agents Chemother; 1982 Jan; 21(1):131-4. PubMed ID: 7081970
[TBL] [Abstract][Full Text] [Related]
2. Relationship between metronidazole metabolism and bactericidal activity.
Chrystal EJ; Koch RL; McLafferty MA; Goldman P
Antimicrob Agents Chemother; 1980 Oct; 18(4):566-73. PubMed ID: 6255861
[TBL] [Abstract][Full Text] [Related]
3. Isolation and properties of metronidazole-resistant mutants of Bacteroides fragilis.
Britz ML; Wilkinson RG
Antimicrob Agents Chemother; 1979 Jul; 16(1):19-27. PubMed ID: 475371
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
[TBL] [Abstract][Full Text] [Related]
6. Lactate dehydrogenase activity as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295.
Narikawa S; Suzuki T; Yamamoto M; Nakamura M
J Antimicrob Chemother; 1991 Jul; 28(1):47-53. PubMed ID: 1769942
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Bacteroides fragilis resistance to metronidazole.
Ghotaslou R; Bannazadeh Baghi H; Alizadeh N; Yekani M; Arbabi S; Memar MY
Infect Genet Evol; 2018 Oct; 64():156-163. PubMed ID: 29936037
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related species.
Haller I
Antimicrob Agents Chemother; 1982 Jul; 22(1):165-6. PubMed ID: 7125628
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R
Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
Soriano F; Ponte MC; Gaspar MC
J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
[TBL] [Abstract][Full Text] [Related]
11. Formation of an amino reduction product of metronidazole in bacterial cultures: lack of bactericidal activity.
Ehlhardt WJ; Beaulieu BB; Goldman P
Biochem Pharmacol; 1987 Jan; 36(2):259-64. PubMed ID: 3545214
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate dehydrogenase activity and metronidazole susceptibility in Bacteroides fragilis.
Tabaqchali S; Pantosti A; Oldfield S
J Antimicrob Chemother; 1983 May; 11(5):393-400. PubMed ID: 6874627
[TBL] [Abstract][Full Text] [Related]
13. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
Dijkmans BA; Mattie H; Hermans J; van Furth R
J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
[TBL] [Abstract][Full Text] [Related]
15. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
Shimada K; Inamatsu T; Sato K
Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
[TBL] [Abstract][Full Text] [Related]
16. Cloning of Bacteroides fragilis plasmid genes affecting metronidazole resistance and ultraviolet survival in Escherichia coli.
Wehnert GU; Abratt VR; Goodman HJ; Woods DR
Plasmid; 1990 Mar; 23(2):155-8. PubMed ID: 2194230
[TBL] [Abstract][Full Text] [Related]
17. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.
Betriu C; Cabronero C; Gomez M; Picazo JJ
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):352-6. PubMed ID: 1396757
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole-resistant Bacteroides fragilis wound infection.
O'Donoghue MA; Potter J; Allen KD
J Infect; 1992 Sep; 25(2):211-4. PubMed ID: 1431176
[TBL] [Abstract][Full Text] [Related]
19. Activity of metronidazole on Bacteroides fragilis and/or Escherichia coli in vitro and in vivo.
Rylander M; Holm SE; Brorson JE; Johnsson J; Norrby R
J Antimicrob Chemother; 1981 Mar; 7(3):257-67. PubMed ID: 7024242
[No Abstract] [Full Text] [Related]
20. Enhanced pathogenicity of susceptible strains of the Bacteroides fragilis group subjected to low doses of metronidazole.
Diniz CG; Arantes RM; Cara DC; Lima FL; Nicoli JR; Carvalho MA; Farias LM
Microbes Infect; 2003 Jan; 5(1):19-26. PubMed ID: 12593969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
